SELLAS Life Sciences Group (SLS) Assets Average: 2011-2024
Historic Assets Average for SELLAS Life Sciences Group (SLS) over the last 7 years, with Sep 2024 value amounting to $20.8 million.
- SELLAS Life Sciences Group's Assets Average rose 56.18% to $20.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $20.8 million, marking a year-over-year increase of 56.18%. This contributed to the annual value of $13.6 million for FY2023, which is 42.48% down from last year.
- Per SELLAS Life Sciences Group's latest filing, its Assets Average stood at $20.8 million for Q3 2024, which was up 5.24% from $19.8 million recorded in Q2 2024.
- In the past 5 years, SELLAS Life Sciences Group's Assets Average ranged from a high of $43.3 million in Q1 2021 and a low of $7.2 million during Q4 2023.
- Over the past 3 years, SELLAS Life Sciences Group's median Assets Average value was $23.5 million (recorded in 2022), while the average stood at $20.8 million.
- In the last 5 years, SELLAS Life Sciences Group's Assets Average soared by 166.96% in 2021 and then tumbled by 69.53% in 2023.
- Over the past 5 years, SELLAS Life Sciences Group's Assets Average (Quarterly) stood at $32.3 million in 2020, then declined by 0.51% to $32.1 million in 2021, then decreased by 26.91% to $23.5 million in 2022, then plummeted by 69.53% to $7.2 million in 2023, then surged by 56.18% to $20.8 million in 2024.
- Its Assets Average stands at $20.8 million for Q3 2024, versus $19.8 million for Q2 2024 and $15.3 million for Q1 2024.